Migasena S, Suntharasamai P, Pitisuttithum P, Kitayaporn D, Wasi C, Huang W, Vanichseni S, Koompong C, Kaewkungwal J, Raktham S, ppolito T, Hanson C, Gregory T, Heyward WL, Berman P, Francis D. AIDSVAX^Ò (MN) in Bangkok injecting drug user: A report on safety and immunogenicity including mocrophage tropic virus neutralizing.  AIDS Res Hum Retroviruses 2000; 16:655-63.

Pitisuttithum P, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai L, Kitayaporn D, Kaewkangwal J, Migasean S, Hiranrus K, Berman P, Chernow M and Francis D. Phase I/II Safety and Immunogenicity Trial of Bivalent rgp120 HIV Vaccine (AIDSVAX^TM B/E) in Bangkok, Thailand-Initial Report (Abstract).The Third Annual Conference on Vaccine Research, Washington DC. April 30-May 2, 2000 p.48

Pitisuttithum P, Bangkok Vaccine Evaluation Group. Social harm monitoring among injecting drug users (IDUs) in a phase III HIV vaccine trial in Bangkok, Thailand-preliminary results.(Abstract).  XII International AIDS Conference Durban, South Africa, 9-14 July 2000 p.443

Pitisuttithum P, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai L, Hiranrus K, Kitayaporn  D., et al. Initial Report of a Phase I/II Safety and Immunogenicity Trial AIDSVSX^TM B/E  rgp120 HIV  Vaccine – Bangkok, Thailand. (Abstract).  XII International AIDS Conference  Durban,South Africa, 9-14 July 2000

Pitisuttithum P, and Thai AIDS Vaccine Evaluation Group. Phase II Trial of HIV-1 Subtype E and B gp120 Vaccines in Seronegative Thai Adults. (Abstract).  XII International AIDS Conference  Durban,South Africa, 9-14 July 2000

Home